Castlight Health, inc. (NYSE:CSLT) was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a report released on Wednesday.

A number of other research firms have also weighed in on CSLT. Cowen and Company reaffirmed a “market perform” rating and issued a $4.50 price objective (up previously from $4.00) on shares of Castlight Health, inc. in a research note on Thursday, August 3rd. ValuEngine raised Castlight Health, inc. from a “sell” rating to a “hold” rating in a research note on Tuesday, August 1st. Zacks Investment Research raised Castlight Health, inc. from a “sell” rating to a “hold” rating in a research note on Tuesday, June 27th. Dougherty & Co reaffirmed a “buy” rating on shares of Castlight Health, inc. in a research note on Thursday, August 17th. Finally, Chardan Capital began coverage on Castlight Health, inc. in a research note on Tuesday, June 6th. They issued a “buy” rating and a $4.50 price objective for the company. Three investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company’s stock. Castlight Health, inc. presently has a consensus rating of “Hold” and an average target price of $4.57.

Castlight Health, inc. (CSLT) traded down 2.41% during mid-day trading on Wednesday, hitting $4.05. The company’s stock had a trading volume of 860,988 shares. Castlight Health, inc. has a 52-week low of $3.05 and a 52-week high of $5.50. The stock’s market cap is $318.24 million. The company’s 50 day moving average is $3.99 and its 200-day moving average is $3.89.

Castlight Health, inc. (NYSE:CSLT) last released its quarterly earnings data on Wednesday, August 2nd. The software maker reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.02. The firm had revenue of $32.10 million during the quarter, compared to analyst estimates of $31.14 million. Castlight Health, inc. had a negative return on equity of 36.30% and a negative net margin of 42.54%. The business’s quarterly revenue was up 36.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.11) earnings per share. On average, equities analysts predict that Castlight Health, inc. will post ($0.25) EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Castlight Health, inc. (CSLT) Lifted to “Sell” at BidaskClub” was first posted by American Banking News and is the sole property of of American Banking News. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/09/17/castlight-health-inc-cslt-lifted-to-sell-at-bidaskclub.html.

In other Castlight Health, inc. news, CFO Mangini Siobhan Nolan sold 28,414 shares of the company’s stock in a transaction that occurred on Thursday, August 17th. The stock was sold at an average price of $3.66, for a total transaction of $103,995.24. Following the sale, the chief financial officer now directly owns 41,622 shares in the company, valued at $152,336.52. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO John C. Doyle sold 35,184 shares of the company’s stock in a transaction that occurred on Thursday, August 17th. The shares were sold at an average price of $3.65, for a total value of $128,421.60. Following the sale, the chief executive officer now owns 75,639 shares in the company, valued at $276,082.35. The disclosure for this sale can be found here. Insiders sold 208,287 shares of company stock worth $795,240 over the last quarter. 37.43% of the stock is owned by company insiders.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Oxford Asset Management bought a new position in shares of Castlight Health, inc. during the first quarter valued at approximately $102,000. Voya Investment Management LLC grew its stake in Castlight Health, inc. by 25.4% in the second quarter. Voya Investment Management LLC now owns 26,929 shares of the software maker’s stock worth $112,000 after purchasing an additional 5,453 shares in the last quarter. Stifel Financial Corp grew its stake in Castlight Health, inc. by 4.3% in the first quarter. Stifel Financial Corp now owns 36,500 shares of the software maker’s stock worth $133,000 after purchasing an additional 1,500 shares in the last quarter. Nationwide Fund Advisors grew its stake in Castlight Health, inc. by 49.5% in the second quarter. Nationwide Fund Advisors now owns 36,418 shares of the software maker’s stock worth $151,000 after purchasing an additional 12,061 shares in the last quarter. Finally, FNY Partners Fund LP bought a new position in Castlight Health, inc. in the first quarter worth approximately $164,000. 41.30% of the stock is currently owned by hedge funds and other institutional investors.

About Castlight Health, inc.

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Analyst Recommendations for Castlight Health, inc. (NYSE:CSLT)

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.